FDA inspection
CDYMAX (India) Pharma Private Limited: FDA inspection ending Feb 28, 2025
FDA inspection 1265529 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1265529 |
|---|---|
| Firm | CDYMAX (India) Pharma Private Limited |
| FEI number | 3030133758 |
| Address | 243244 Plot No 20, Bommasandra Jigani Link Road; 169 Jigani Hobli |
| City | Bengaluru |
| Fiscal year | 2025 |
| Inspection end date | Feb 28, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data